These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 21591321

  • 1. [The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].
    Schutter U, Ritzdorf I, Heckes B.
    MMW Fortschr Med; 2010 Jul 01; 152 Suppl 2():62-9. PubMed ID: 21591321
    [Abstract] [Full Text] [Related]

  • 2. [Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].
    Böhme K, Heckes B, Thomitzek K.
    MMW Fortschr Med; 2011 Jan 13; 152 Suppl 4():125-32. PubMed ID: 21598463
    [Abstract] [Full Text] [Related]

  • 3. [The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].
    Schutter U, Ritzdorf I, Heckes B.
    MMW Fortschr Med; 2010 Aug 12; 152(31-33):49. PubMed ID: 20828070
    [No Abstract] [Full Text] [Related]

  • 4. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug 12; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Aug 12; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of chronic osteoarthritis pain: effectivity and safety of a 7 day matrix patch with a low dose buprenorphine].
    Schutter U, Ritzdorf I, Heckes B.
    MMW Fortschr Med; 2008 Jun 26; 150 Suppl 2():96-103. PubMed ID: 18712130
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Buprenorphine TDS: use in daily practice, benefits for patients.
    Radbruch L.
    Int J Clin Pract Suppl; 2003 Feb 26; (133):19-22; discussion 23-4. PubMed ID: 12665120
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Tilidine/naloxon retard in long-term administration in chronic pain and multimorbidity. Multicenter study of long-term tolerance and effectiveness in 2 years observation].
    Flöter T, Brunnmüller U.
    Fortschr Med Orig; 2002 Feb 26; 120(1):29-35. PubMed ID: 14518355
    [Abstract] [Full Text] [Related]

  • 11. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R, Kayser H, Sittl R.
    Clin Ther; 2006 Jun 26; 28(6):943-52. PubMed ID: 16860176
    [Abstract] [Full Text] [Related]

  • 12. High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.
    Barutell C, Camba A, González-Escalada JR, Rodríguez M, Opioid Group of the Spanish Society for the Study of Pain.
    Pain Pract; 2008 Jun 26; 8(5):355-61. PubMed ID: 18662364
    [Abstract] [Full Text] [Related]

  • 13. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
    Tschirner M, Ritzdorf I, Brünjes R.
    MMW Fortschr Med; 2008 Sep 18; 150 Suppl 3():142-8. PubMed ID: 19025217
    [Abstract] [Full Text] [Related]

  • 14. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N, Sittl R, Likar R.
    Curr Med Res Opin; 2005 Aug 18; 21(8):1147-56. PubMed ID: 16083522
    [Abstract] [Full Text] [Related]

  • 15. Transdermal buprenorphine in the treatment of chronic pain.
    Sittl R.
    Expert Rev Neurother; 2005 May 18; 5(3):315-23. PubMed ID: 15938664
    [Abstract] [Full Text] [Related]

  • 16. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.
    Radbruch L, Glaeske G, Grond S, Münchberg F, Scherbaum N, Storz E, Tholen K, Zagermann-Muncke P, Zieglgänsberger W, Hoffmann-Menzel H, Greve H, Cremer-Schaeffer P.
    Subst Abus; 2013 May 18; 34(3):313-20. PubMed ID: 23844964
    [Abstract] [Full Text] [Related]

  • 17. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov 18; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C, Failde I, Micó JA, Neira M, Sánchez-Magro I.
    Clin Ther; 2005 Apr 18; 27(4):451-62. PubMed ID: 15922818
    [Abstract] [Full Text] [Related]

  • 19. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F, Ciccozzi A, Aloisio L, Colangeli A, Paladini A, Bajocco C, Coaccioli S, Varrassi G.
    Pain Pract; 2007 Dec 18; 7(4):307-12. PubMed ID: 17986161
    [Abstract] [Full Text] [Related]

  • 20. [Pain therapy in the elderly:7-day transdermal buprenorphine patch in clinical practice. Results of a non-interventional study].
    Wahle K, Krings D, Schwenke K.
    MMW Fortschr Med; 2013 Mar 21; 155 Suppl 1():25-31. PubMed ID: 23678668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.